Diphenyl substituted alkanes as flap inhiibitors

Details for Australian Patent Application No. 2005295646 (hide)

Owner Merck & Co., Inc.

Inventors Chu, Lin; Li, Bing; Ujjainwalla, Feroze; Ogawa, Anthony K.; Kopka, Ihor E.

Agent Spruson & Ferguson

Pub. Number AU-B-2005295646

PCT Pub. Number WO2006/044602

Priority 60/619,752 18.10.04 US

Filing date 14 October 2005

Wipo publication date 27 April 2006

Acceptance publication date 20 November 2008

International Classifications

A61K 31/4439 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/044602 Priority application(s): WO2006/044602

20 November 2008 Application Accepted

  Published as AU-B-2005295646

27 November 2008 Application for Amendment

  The nature of the amendment is: Amend the invention title to read from Diphenyl substituted alkanes as flap inhiibitors to Diphenyl substituted alkanes as flap inhibitors. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2008

26 March 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Diphenyl substituted alkanes as flap inhibitors

26 March 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295654-Method of preventing and treating airway remodeling and pulmonary inflammation using A2B adenosine receptor antagonists

2005295644-Compositions containing piperacillin, tazobactam and a aminocarboxilic acid in a sodium lactate diluent